Related Experiment Video
Updated: May 26, 2025

Enhanced Genome Editing with Cas9 Ribonucleoprotein in Diverse Cells and Organisms
Published on: May 25, 2018
Advanced delivery systems for gene editing: A comprehensive review from the GenE-HumDi COST Action Working Group
Alessia Cavazza1,2, Francisco J Molina-Estévez3,4,5, Álvaro Plaza Reyes6
1Molecular and Cellular Immunology Section, Department of Infection, Immunity & Inflammation, UCL Great Ormond Street Institute of Child Health, University College London, 20 Guilford Street, London WC1N 1DZ, UK.
Genome editing offers precise genetic modification for therapies. This review details viral and non-viral delivery systems for genome editing, crucial for clinical applications.
Area of Science:
- Biotechnology
- Molecular Biology
- Gene Therapy
Background:
- Genome editing technologies, utilizing programmable DNA nucleases, enable precise genetic modifications.
- These technologies hold promise as alternatives to traditional therapeutic strategies.
- Clinical translation of genome editing is challenged by efficient and safe delivery of editing reagents.
Purpose of the Study:
- To review and summarize the diverse delivery systems for genome editing components.
- To highlight the advantages and limitations of various delivery platforms.
- To discuss the potential clinical applications of these delivery systems.
Main Methods:
- Comprehensive literature review of viral and non-viral delivery systems for genome editing.
- Analysis of system efficiency, safety, and scalability.
- Discussion of current challenges and future directions in the field.
Main Results:
- A wide array of delivery systems, including viral vectors (e.g., AAV, lentivirus) and non-viral methods (e.g., lipid nanoparticles, electroporation), are available.
- Each system presents unique advantages and limitations regarding cargo capacity, immunogenicity, targeting efficiency, and manufacturing.
- The choice of delivery system significantly impacts the feasibility and success of genome editing interventions.
Conclusions:
- Effective delivery of genome editing tools is paramount for successful clinical translation.
- Ongoing advancements in both viral and non-viral delivery systems are expanding therapeutic possibilities.
- Further research and development are needed to optimize delivery strategies for enhanced safety and efficacy in clinical settings.
More Related Videos
Related Concept Videos
CRISPR
What is Genetic Engineering?
CRISPR and crRNAs
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
Homologous Recombination
RNA Editing

